NYSE:CAHHealthcare
Cardinal Health Expands Rapiblyk Access And Deepens Critical Care Ties
Cardinal Health (NYSE:CAH) is expanding national hospital access to Rapiblyk, a critical care drug, through its distribution network alongside other major distributors.
The broader availability is intended to reach hospitals and health systems across the United States.
This development extends Cardinal Health's role in supplying therapies used in high-acuity hospital settings.
For you as an investor, this move sits at the core of Cardinal Health's role as a large pharmaceutical and medical...